Enfusion (NYSE:ENFN) Reaches New 1-Year Low Following Insider Selling

Shares of Enfusion, Inc. (NYSE:ENFN – Get Rating) reached a new 52-week low on Monday after an insider sold shares in the company. The company traded as low as $7.77 and last traded at $7.97, with a volume of 59225 shares. The stock had previously closed at $8.07. Specifically, CTO Dan Groman sold 3,877 shares […]

Related Keywords

United States ,Dan Groman ,Piper Sandler ,Asia Pacific ,Stephen Malherbe ,Jpmorgan Chase Co ,Citigroup Inc ,Metlife Investment Management ,Goldman Sachs Group ,Envestnet Asset Management Inc ,Enfusion Inc ,York Mellon Corp ,Get Rating ,Asset Management ,New York Mellon Corp ,Life Investment Management ,Rhumbline Advisers ,Middle East ,Enfusion Daily ,Enfusion ,Nyse Enfn ,Enfn ,Computer And Technology ,Stocks ,Technicals ,